CapsoVision (CV) Enterprise Value (2024 - 2025)
CapsoVision (CV) reported Enterprise Value of -$10.1 million for Q4 2025, down 8.51% on a YoY basis from -$11.1 million in Q4 2024, and up 43.15% sequentially from -$17.8 million in Q3 2025.
CapsoVision (CV) Enterprise Value (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Enterprise Value data on file, last reported at -$10.1 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 8.51% year-over-year to -$10.1 million; the trailing twelve-month figure through Dec 2025 stood at -$10.1 million (down 8.51% YoY), and the FY2025 full-year result was -$10.1 million, down 8.51% from the prior year.
- Enterprise Value grew to -$10.1 million in Q4 2025, from -$17.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q2 2025 to a low of -$17.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | -10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.11 Mn |
| Sep 30, 2025 | -17.79 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Dec 31, 2024 | -9.32 Mn |